发明名称 Chimeric antisense oligonucleotides and cell transfecting formulations thereof
摘要 Chimeric oligonucleotide of the formula 5'-W-X<1>-Y-X<2>-Z-3', where W represents a 5'-O-alkyl nucleotide, each of X<1> and X<2> represented a block of seven to twelve phosphodiester-linked 2'-O-alkyl ribonucleotides, Y represents a block of five to twelve phosphorothioate-linked deoxyribonucleotides, and Z represents a blocking group effective to block nuclease activity at the 3' end of the oligonucleotide, are described. These compounds exhibit high resistance to endo- and exonucleases, high sequence specificity, and the ability to activate RNAse H, as evidenced by efficient and long-lasting suppression of target mRNA. The oligonucleotides are preferably transfected into cells in formulations containing a lipid-peptoid conjugate carrier molecule of the formula L-linker-[N(CH2CH2NH2)CH2(C=O)-N(CH2CH2R)CH2(C=O)-N(CH2CH2R)CH2(C=O)]3-NH2, where L is a lipid moiety, including a steroid, and each group R is independently selected from alkyl, aminoalkyl, and aralkyl.
申请公布号 AU7070800(A) 申请公布日期 2001.03.26
申请号 AU20000070708 申请日期 2000.08.25
申请人 CHIRON CORPORATION 发明人 MICHAEL A. INNIS;CHRISTOPH J. REINHARD;RONALD N ZUCKERMANN
分类号 C12N15/09;A61K31/7125;A61K38/00;A61K47/48;A61K48/00;A61P43/00;C07H21/04;C12N15/113 主分类号 C12N15/09
代理机构 代理人
主权项
地址